Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Chronic Obstructive Pulmonary Disease|April 10, 2019
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPDSanjay Sethi, Edward Kerwin, Henrik Watz, et al.
BMC Pulmonary Medicine|November 19, 2014
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised studyDave Singh, Paul W Jones, Eric D Bateman, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2023
The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese ParticipantsWeimin Li, Sami Z Daoud, Roopa Trivedi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENTAnthony D D'Urzo, Dave Singh, James F Donohue, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2017
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPDHenrik Watz, Thierry Troosters, Kai M Beeh, et al.
Drugs in R&D|February 8, 2022
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseHong Zhang, Sami Z Daoud, Michael S Gillen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 28, 2022
Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE StudyMaud Koopman, Frits M E Franssen, Swetlana Gaffron, et al.
Pageof 2